| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |